Killing a Terrorist Leader Can Backfire

Killing a Terrorist Leader Can Backfire

Top of Mind with Julie Rose - Radio Archive, Episode 767 , Segment 6

Episode: Tillerson Out, Best Time to Have a Heart Attack, Breast Cancer Genetics Testing

  • Mar 13, 2018 11:00 pm
  • 21:04 mins

Guest: Tricia Bacon, PhD, Assistant Professor of Public Affairs, American University Shortly after Barack Obama took office in 2009, he made killing or capture of Osama Bin Laden the top priority of America’s war against al Qaeda. In 2011, they got him. But cutting off the head did not kill the proverbial snake in this case. In fact, killing Bin Laden may have hastened the rise of ISIS, whose tactics have been even more brutal than Al Qaeda's.

Other Segments

23andMe Breast Cancer Genetics Testing

11 MINS

Guest: Laura Hercher, MS, Director of Student Research, Joan H. Marks Graduate Program in Human Genetics, Sarah Lawrence College If you send in a sample of your saliva to 23andMe, the genetics-testing company will send you a report about where your ancestors came from, and you can pay extra to find out if you’re at risk for Parkinson’s or Late-Onset Alzheimer’s. Just last week, the Federal Drug Administration also gave 23andMe the green light to screen for three mutations that increase the risk of breast and ovarian cancer. It was screening positive for mutations on these BRCA genes that led Angelina Jolie to have a double mastectomy. This is the first time the FDA has authorized this screening by a company selling directly to consumers.

Guest: Laura Hercher, MS, Director of Student Research, Joan H. Marks Graduate Program in Human Genetics, Sarah Lawrence College If you send in a sample of your saliva to 23andMe, the genetics-testing company will send you a report about where your ancestors came from, and you can pay extra to find out if you’re at risk for Parkinson’s or Late-Onset Alzheimer’s. Just last week, the Federal Drug Administration also gave 23andMe the green light to screen for three mutations that increase the risk of breast and ovarian cancer. It was screening positive for mutations on these BRCA genes that led Angelina Jolie to have a double mastectomy. This is the first time the FDA has authorized this screening by a company selling directly to consumers.